G B, Bhat R, G M, Kanthappa B
Sci Rep. 2025; 15(1):6651.
PMID: 39994221
PMC: 11850592.
DOI: 10.1038/s41598-025-86927-7.
Singer C, Varut R, Singer M, Cosoveanu S, Abdul Razzak J, Popescu M
Children (Basel). 2025; 12(1).
PMID: 39857875
PMC: 11764207.
DOI: 10.3390/children12010044.
Cha H, Han C, Jeon J, Jeong J, Jung I, Yang C
J Pain Res. 2024; 17:2203-2221.
PMID: 38947130
PMC: 11213161.
DOI: 10.2147/JPR.S457425.
Miszczuk E, Bajguz A, Kiraga L, Crowley K, Chlopecka M
Pharmaceuticals (Basel). 2024; 17(5).
PMID: 38794127
PMC: 11124171.
DOI: 10.3390/ph17050557.
Balram D, Lian K, Sebastian N
Sensors (Basel). 2023; 23(1).
PMID: 36616981
PMC: 9823579.
DOI: 10.3390/s23010379.
N-Acetylcysteine for Preventing Acetaminophen-Induced Liver Injury: A Comprehensive Review.
Licata A, Minissale M, Stankeviciute S, Sanabria-Cabrera J, Lucena M, Andrade R
Front Pharmacol. 2022; 13:828565.
PMID: 36034775
PMC: 9399785.
DOI: 10.3389/fphar.2022.828565.
Adrenergic blocker terazosin potentially suppresses acetaminophen induced-acute liver injury in animal models via CYP2E1 gene.
Hashmat Z, Channa I, Safdar M, Ozaslan M, Saeed M, Siddique F
Toxicol Res. 2022; 38(3):323-330.
PMID: 35874506
PMC: 9247125.
DOI: 10.1007/s43188-021-00116-y.
Acute paracetamol poisonings received at the Oran University Hospital.
Chefirat B, Zergui A, Rahmani C, Belmessabih M, Rezk-Kallah H
Toxicol Rep. 2020; 7:1172-1177.
PMID: 32983905
PMC: 7494939.
DOI: 10.1016/j.toxrep.2020.08.025.
Paracetamol self-poisoning: when oral N-acetylcysteine saves life? a case report.
Benlamkaddem S, Iken I, Houari N, Elbouazzaoui A, Boukatta B, Sbai H
Pan Afr Med J. 2018; 29:83.
PMID: 29875964
PMC: 5987070.
DOI: 10.11604/pamj.2018.29.83.10595.
Interventions for paracetamol (acetaminophen) overdose.
Chiew A, Gluud C, Brok J, Buckley N
Cochrane Database Syst Rev. 2018; 2:CD003328.
PMID: 29473717
PMC: 6491303.
DOI: 10.1002/14651858.CD003328.pub3.
Paracetamol (acetaminophen) for chronic non-cancer pain in children and adolescents.
Cooper T, Fisher E, Anderson B, Wilkinson N, Williams D, Eccleston C
Cochrane Database Syst Rev. 2017; 8:CD012539.
PMID: 28770975
PMC: 6484395.
DOI: 10.1002/14651858.CD012539.pub2.
Pharmacokinetic modelling of modified acetylcysteine infusion regimens used in the treatment of paracetamol poisoning.
Wong A, Landersdorfer C, Graudins A
Eur J Clin Pharmacol. 2017; 73(9):1103-1110.
PMID: 28624886
DOI: 10.1007/s00228-017-2277-4.
How Should We Respond to Non-Dominant Healing Practices, the Example of Homeopathy.
Gray B
J Bioeth Inq. 2016; 14(1):87-96.
PMID: 27975156
DOI: 10.1007/s11673-016-9760-y.
The 100 most influential publications in paracetamol poisoning treatment: a bibliometric analysis of human studies.
Zyoud S, Waring W, Al-Jabi S, Sweileh W, Awang R
Springerplus. 2016; 5(1):1534.
PMID: 27652107
PMC: 5019997.
DOI: 10.1186/s40064-016-3240-z.
Hepatotoxicity induced by acute and chronic paracetamol overdose in children: Where do we stand?.
Tong H, Medrano N, Borobia A, Ruiz J, Martinez A, Martin J
World J Pediatr. 2016; 13(1):76-83.
PMID: 27457792
DOI: 10.1007/s12519-016-0046-6.
Paracetamol for low back pain.
Saragiotto B, Machado G, Ferreira M, Pinheiro M, Abdel Shaheed C, Maher C
Cochrane Database Syst Rev. 2016; (6):CD012230.
PMID: 27271789
PMC: 6353046.
DOI: 10.1002/14651858.CD012230.
Determinants of hepatotoxicity after repeated supratherapeutic paracetamol ingestion: systematic review of reported cases.
Acheampong P, Thomas S
Br J Clin Pharmacol. 2016; 82(4):923-31.
PMID: 27261770
PMC: 5137817.
DOI: 10.1111/bcp.13028.
A review of the evidence concerning hepatic glutathione depletion and susceptibility to hepatotoxicity after paracetamol overdose.
Kalsi S, Dargan P, Waring W, Wood D
Open Access Emerg Med. 2016; 3:87-96.
PMID: 27147856
PMC: 4753970.
DOI: 10.2147/OAEM.S24963.
Does cytochrome P450 liver isoenzyme induction increase the risk of liver toxicity after paracetamol overdose?.
Kalsi S, Wood D, Waring W, Dargan P
Open Access Emerg Med. 2016; 3:69-76.
PMID: 27147854
PMC: 4753969.
DOI: 10.2147/OAEM.S24962.
N-Acetyl cysteine does not prevent liver toxicity from chronic low-dose plus subacute high-dose paracetamol exposure in young or old mice.
Kane A, Huizer-Pajkos A, Mach J, McKenzie C, Mitchell S, de Cabo R
Fundam Clin Pharmacol. 2016; 30(3):263-75.
PMID: 26821200
PMC: 4864111.
DOI: 10.1111/fcp.12184.